The Global Market for EPA/DHA Omega-3 Products
Packaged Facts projects the market value of EPA/ DHA omega-3 packaged products to reach $34.7 billion in 2016, representing a compound annual growth rate (CAGR) of 6.4% over 2011. Expanding public awareness of EPA/DHA omega-3 health benefit through positive media coverage of scientific research findings, as well as developments in regulatory markets, will contribute significantly to continued growth in the global market for EPA/DHA omega-3 products. Other factors that will continue to create a positive growth environment for EPA/DHA omega-3 products include:
- Consumer interest in functional food and fortified product line expansions;
- Increasing demand for fortified infant formula due to population growth and rising middle class in emerging economies;
- Continued popularity of EPA/DHA omega-3 nutritional supplement products, including krill oil and vegetarian algae-based supplements;
- Introduction of pharmaceutical-grade products into South America and approval of generic forms in existing markets;
- Expanding clinical nutrition market opportunities for disease- and disorder-specific formula applications, created through additional R & D and aggressive marketing by ingredient suppliers; and
- Premiumization of pet foods due to humanization of companion animals.
The geographic scope of this report is global, broken out into four regions: North America (United States and Canada); Europe (Scandinavia, Western Europe, Eastern Europe and Russia); Asia Pacific (China, Japan, South and Southeast Asia, Australia, New Zealand and Oceania); and Rest of World (Latin America, Middle East and Africa). Six categories of packaged consumer products are covered by this report: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition (enteral and parenteral) products; and pet food, treats and supplements.
The base year for market sizing is 2011, with projections for 2016. All market size figures and projections are calculated in U.S. dollars.
The information contained in this report was obtained from primary and secondary research. Primary research entailed approximately one hundred interviews with industry insiders across geographic regions and product categories. Representatives from ingredient suppliers and consumer product manufacturers were interviewed, including special cooperation by GOED members. Consultations with other industry players and on-site examination of retail products also formed part of this study. Secondary research included extensive Internet canvassing and data gathering from relevant business and industry media; company information in annual reports, press releases, conference calls and investor presentations; product profiles in trade and consumer publications; GOED presentations and databases; published reports and studies; and related food and nutrition market reports by Packaged Facts. Sales estimates and forecasts are based on analysis of data and information from these sources.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.